Publication
What M&A trends will transform the 2024 insurance landscape?
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Global | Publication | November 2018
Pharmaceutial and Medical Device Law, published by the ABA Health Law Section and Bloomberg BNA, provides readers with an overview of key legal and regulatory issues that impact the development and marketing activities of pharmaceutical and medical device companies.
Carol Poindexter, Paul Sumilas and Vijay Rao have contributed to Chapter 8 (Federal Sentencing Guidelines and Compliance Measures), which covers topics such as
Publication
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Publication
The ongoing conflicts and further geopolitical tensions in Eastern Europe and the Middle East, coupled with upcoming elections in a number of key countries including the US and the UK, make 2024 challenging to predict what impact this will have on the insurance sector.
Publication
On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the administrative stage of a legal saga that has attracted interest beyond competition law specialists.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023